id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-E-0397-0007,FDA,FDA-2013-E-0397,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2016-12-29T05:00:00Z,2016,12,2016-12-29T05:00:00Z,,2016-12-29T17:24:51Z,,0,0,090000648243dfe0
FDA-2013-E-0397-0006,FDA,FDA-2013-E-0397,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2015-12-01T05:00:00Z,2015,12,2015-12-01T05:00:00Z,,2015-12-01T20:42:36Z,,0,0,0900006481d7e3e2
FDA-2013-E-0397-0005,FDA,FDA-2013-E-0397,"Determination of Regulatory Review Period for Purposes of Patent
Extension; ISTENT TRABECULAR MICRO-BYPASS STENT",Notice,Determinations,2015-05-07T04:00:00Z,2015,5,2015-05-07T04:00:00Z,2015-11-04T04:59:59Z,2015-05-07T15:54:40Z,2015-10999,0,0,0900006481ad2840
FDA-2013-E-0397-0004,FDA,FDA-2013-E-0397,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2015-04-23T04:00:00Z,2015,4,2015-04-23T04:00:00Z,,2015-04-23T12:42:14Z,,0,0,0900006481ab4bc4
FDA-2013-E-0397-0003,FDA,FDA-2013-E-0397,Letter from FDA CDER to U.S. Patent and Tradekmark Office,Other,Letter(s),2014-02-03T05:00:00Z,2014,2,2014-02-03T05:00:00Z,,2014-02-03T13:48:31Z,,0,0,090000648153cc7e
FDA-2013-E-0397-0001,FDA,FDA-2013-E-0397,U.S. Patent and Trademark Office - Letter,Other,Letter(s),2013-04-05T04:00:00Z,2013,4,2013-04-05T04:00:00Z,,2013-04-05T14:24:27Z,,0,0,090000648126ddc9
FDA-2013-E-0397-0002,FDA,FDA-2013-E-0397,Glaukos Corporation (Knobbe Martens Olson & Bear LLP) - Patent Extension  Application,Other,Application,2013-04-05T04:00:00Z,2013,4,2013-04-05T04:00:00Z,,2013-04-05T14:29:08Z,,0,0,090000648126b8a5